Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Headlines

Roche sees high single-digit core profit growth in 2025

Published by Global Banking & Finance Review

Posted on January 30, 2025

1 min read

· Last updated: January 27, 2026

Add as preferred source on Google

This image features the Roche logo alongside a financial growth chart, illustrating the company's target for high single-digit core profit growth in 2025, as reported in the banking and finance news article.

corporate profits financial markets investment managers

Global Banking & Finance Awards 2026 — Call for Entries

By Ludwig Burger FRANKFURT (Reuters) - Swiss drugs and diagnostics company Roche said on Thursday it is targeting an increase in core 2025 earnings per share in a high single-digit percentage range,